Nk-cell Lymphoma

• CLINICAL_TRIALS trial_result · 2021-08-11
  Clinical Trial Update: A Prospective Clinical Study of Ruxolitinib and Etoposide Combined With DDGP Regimen (RUE-DDGP) in Induction Therapy of T/NK Cell Lymphoma-associated Hemophagocytic Syndrome. [Phase 4]

  Clinical trial investigating ruxolitinib and etoposide with the DDGP regimen for induction therapy in T/NK cell lymphoma-associated hemophag…

• CLINICAL_TRIALS trial_result · 2019-04-17
  Clinical Trial Update: Pembrolizumab for T/NK-cell lymphomasNK-cell Lymphomas [Phase 2]

  Phase 2 trial update of pembrolizumab for T-cell lymphoma and NK-cell lymphoma is in progress with unknown status.